Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Sebelipase alfa

Australian Public Assessment Report

AusPAR

AusPAR: Sebelipase alfa [PDF, 973.6 KB]

AusPAR: Sebelipase alfa [DOCX, 1.36 MB]

Attachment: Product Information: Sebelipase alfa [PDF, 296.39 KB]

Attachment: Product Information: Sebelipase alfa [DOCX, 246.75 KB]

Attachment: Extract from Clinical Evaluation Sebelipase alfa [PDF, 3.62 MB]

Attachment: Extract from Clinical Evaluation Sebelipase alfa [DOCX, 6.16 MB]

Device/Product Name

Kanuma

Active ingredients

Sebelipase alfa

AusPAR Date

14 June 2018

Published

19 July 2018

Submission Number

PM-2016-01313-1-3

Submission Type

New biological entity

Decision

Approved

Product types

Prescription medicines